Pravastin put to test

January 23, 1998

Investigators from Glasgow University, Glasgow Royal Infirmary and Cork and Leiden Universities are starting the first study of the effects of pravastin, a medication widely prescribed to prevent heart attacks in people aged 70 and over. The study, being led by James Shepherd, Glasgow University's professor of pathological biochemistry, will enrol 5,500 patients from the United Kingdom, Ireland and the Netherlands.

You've reached your article limit.

Register to continue

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments
Register

Have your say

Log in or register to post comments